How should I evaluate and manage a 66-year-old patient with diabetes who has had a one-month sensation of walking on something while wearing shoes, despite a normal foot examination?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diabetic Peripheral Neuropathy with Dysesthesia

This patient has diabetic peripheral neuropathy (DPN) with dysesthesia—the sensation of "walking on something" is a classic small-fiber neuropathy symptom described as "walking barefoot on marbles" or "walking barefoot on hot sand" 1. Despite your normal visual examination, this patient requires immediate structured sensory testing and risk stratification.

Immediate Evaluation Required

Your normal visual examination is insufficient. Patients with diabetes frequently have unreliable self-assessment of foot health—87% of those who considered their feet normal had objective abnormalities on examination 2. You must perform:

Mandatory Sensory Testing (Do This Today)

Perform annual screening with both small-fiber and large-fiber testing 3:

  • Small-fiber function: Test pinprick sensation and temperature perception (this is likely where your patient's pathology lies, given the dysesthesia)
  • Large-fiber function: Use a 128-Hz tuning fork for vibration testing
  • Protective sensation: 10-g monofilament testing at multiple plantar sites—this is mandatory annually for all diabetic patients 3

The monofilament test identifies loss of protective sensation (LOPS), which predicts ulceration risk even when patients report no symptoms 3.

What You're Looking For Beyond "Nothing Visible"

During re-examination, specifically assess 4:

  • Foot deformities (hammer toes, bunions, Charcot changes)
  • Dry skin and fissures (autonomic neuropathy)
  • Callus formation (pressure points)
  • Ankle-brachial index if peripheral arterial disease suspected
  • Temperature differences between feet (>2°C suggests Charcot or infection)

Clinical Reasoning

This patient's symptom is neuropathic dysesthesia, not a mechanical foreign body. The one-month duration with normal appearance makes foreign body, plantar wart, or acute injury unlikely. The description fits the altered sensory perception of small-fiber neuropathy 1.

Common pitfall: Dismissing subjective sensory complaints when visual examination appears normal. Up to 50% of DPN patients experience painful symptoms, and dysesthesias often precede objective sensory loss 1.

Management Algorithm

1. Risk Stratification (Based on Your Testing)

If monofilament testing shows LOPS 3:

  • High risk for ulceration
  • Requires podiatry referral
  • Prescribe appropriate therapeutic footwear
  • Intensive foot care education

If sensory testing confirms neuropathy without LOPS:

  • Moderate risk
  • Annual monitoring becomes critical
  • Address symptom management

2. Optimize Glycemic Control First

This is the only intervention proven to prevent or delay neuropathy progression 3. Review her HbA1c and intensify diabetes management if needed.

3. Symptom Management for Dysesthesia

While guidelines don't specifically address isolated dysesthesia without pain, if symptoms affect quality of life 1:

  • First-line pharmacologic options include tricyclic antidepressants, SNRIs (duloxetine), or gabapentinoids
  • However, prioritize glycemic optimization before adding medications

4. Preventive Foot Care Education

Implement immediately to prevent ulceration 3:

  • Daily foot self-inspection (use mirror for plantar surface)
  • Proper footwear (no walking barefoot, even indoors)
  • Moisturize dry skin (not between toes)
  • Professional nail care if vision/mobility impaired

Red Flags Requiring Urgent Referral

  • Foot temperature asymmetry >2°C (possible acute Charcot) 5
  • Any skin breakdown or ulceration
  • Signs of infection
  • Sudden worsening of symptoms

Documentation and Follow-up

Document your sensory testing results specifically—this establishes baseline for annual comparison and medicolegal protection 3. Schedule follow-up in 3 months to reassess symptoms and ensure glycemic optimization, then annually thereafter with repeated comprehensive foot examination 3.

The sensation she describes is her neuropathy manifesting, not something you're missing on examination. Your job now is quantifying the neuropathy severity and preventing the progression to ulceration and amputation 3.

Related Questions

What is the appropriate evaluation and management for severe foot swelling?
For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
What is the clinical significance of a +1 glucose result on a urine dipstick and how should it be evaluated?
Can performing 100 repetitions of moderate-to-heavy resistance exercises on large muscle groups every other day for 15 minutes improve insulin sensitivity and help manage pre-diabetes?
What is an appropriate ketamine taper schedule, including dose reduction percentages, interval timing, monitoring parameters, and adjunctive measures to minimize withdrawal symptoms?
What is the recommended outpatient management for ascites, including low‑sodium diet, diuretic regimen, and criteria for therapeutic paracentesis or TIPS?
What antibiotics are recommended for treating a non-drainable nipple abscess in an adult woman?
What is the proper sterile technique for removing a split urinary catheter?
What is an appropriate tapering plan for a patient who has been taking ketamine 1 ml three times daily for the past two months?
Is the patient more likely to develop ventricular fibrillation (VF) during catheterization when the left ventricular (LV) chamber is engaged versus when a coronary artery is engaged?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.